Related Experiment Video

Updated: Jul 17, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Expression of C-terminal src kinase in human colorectal cancer cell lines

N Watanabe1, S Matsuda, S Kuramochi

  • 1Department of Nuclear Medicine, Gunma University School of Medicine, Maebashi.

Japanese Journal of Clinical Oncology
|February 1, 1995
PubMed

Insights

C-terminal src kinase (CSK) is often elevated in colorectal cancer cells. This suggests CSK may not inhibit cancer development by regulating Src family kinases in colorectal carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • C-terminal src kinase (CSK) is a key regulator of Src family protein-tyrosine kinases.
  • Dysregulation of Src family kinases is implicated in various cancers, including colorectal cancer.

Purpose of the Study:

  • To investigate the expression levels of CSK in human colorectal normal and cancer cell lines.
  • To determine the potential role of CSK in colorectal carcinogenesis.

Main Methods:

  • Production of a specific polyclonal antibody for CSK.
  • Immunoblotting analysis to detect CSK expression in 2 normal and 18 colorectal cancer cell lines.

Main Results:

  • CSK was detected in all analyzed normal and cancer cell lines.
  • CSK expression was generally higher in colorectal cancer cell lines compared to normal cell lines.
  • Elevated CSK expression correlated with increased Src family kinase activity observed in previous studies.

Conclusions:

  • CSK expression is upregulated in colorectal cancer.
  • CSK may not exert an anti-oncogenic effect through negative regulation of Src family kinases in colorectal carcinogenesis.
  • Further research is needed to elucidate the precise role of CSK in colorectal cancer development.

More Related Videos

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...